PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner,
|
|
- Alannah Parrish
- 5 years ago
- Views:
Transcription
1 PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner, MD,PhD,FRCP(Lond),FESC,FACC University Hospital Center Zagreb, University of Zagreb, Zagreb School of Medicine, Croatia
2 CAUSES OF DEATH IN CROATIA IN 2008 Izvor podataka: Državni zavod za statistiku, Hrvatski zavod za javno zdravstvo
3 PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA GENERAL POPULATION A questionnaire with 25 multiple choice questions In 37 pharmacies covering the whole area of Croatia consecutively to all customers willing to answer 883 respondents (questionnaires finished) September 1 to November 30, 2007
4 PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA PHYSICIANS In Croatia physicians (1753 GPs and 927 specialists in GP/family medicine, 987 general internists, 203 cardiologists) randomly recruited using national physicians registry and professional societies directories 5 regions, all cardiologists, every third GP/FP, every fifth internist A questionnaire with 25 multiple choice questions 1382 physicians (930 GP/FP, 165 cardiologists, 213 internists) answered March 1 to June 30, 2008
5 PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA MEDICAL STUDENTS A questionnaire with 25 multiple choice questions 443 medical students at the beginning of the study and at the end of the study On the enrolment day and graduation day September 2008 School of Medicine, University of Zagreb
6 PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA MEMBERS OF PARLIAMENT 77 out of 141 members of the Croatian Parliament - Sabor One day during the Parliament session in the Houses of Parliament 2008 A questionnaire with 25 multiple choice questions
7 PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA JOURNALISTS A questionnaire with 25 multiple choice questions 129 journalists from daily press newspaper, TV, radio In the Croatian Press Association House One day in 2008
8 Age Groups Distribution (years) 46,9% 35,9% 31,5% 24,0% 26,2% 28,8% 27,1% 27,1% 22,8% 19,0% 23,3% 23,9% General Pupolation Journalists Politicians Doctors 16,3% 7,9% 1,6% 1,1% 0% 0% 0% 0% 5,4% 6,8% 8,7% 3,9% 9,6% 2,2% 0% 0% 0% 0% 0% 0% >85 Medical Students all belong to the age group
9 Groups by Gender General Population Journalists 47% 53% 44% 56% Medical Students Politicians 67,42% 32,58% 59,72% 40,28% Male Female
10 Knowledge of Blood Pressure General Population Journalists 13% 26% 74% 87% Know Their Blood Pressure Don't know/no Answer Medical Students Politicians 18% 82% 10% 90%
11 Knowledge of Cholesterol Levels General Population Journalists 58% 42% 57% 43% Know Their Level Don't Know Level/No Answer Medical Students Politicians 26% 21% 74% 79%
12 Awareness of Bad Cholesterol 83,5% 56,8% 54,3% General Population Journalists Medical Students Politicians 31,0% 14,7% 10,9% 9,9% 12,0% 5,3% 26,4% 27,3% 20,2% 14,1% 8,7% 7,8% 5,3% 5,3% 2,7% 2,0% 1,8% HDL Cholesterol LDL Cholesterol Triglycerides None of Mentioned No Answer/Invalid Answer
13 Awareness of Good Cholesterol 82,4% 62,3% Population Journalists Medical Students Politicians 45,0% 50,0% 23,9% 26,4% 26,0% 16,3% 12,0% 9,8% 5,2% 2,2% 3,1% 0,9% 1,3% 14,1% 9,3% 5,2% 2,5% 2,3% HDL Cholesterol LDL Cholesterol Triglycerides None of Mentioned No Answer/Invalid Answer
14 Fear of Listed Diseases 63,9% 40,0% 48,6% 42,9% General Population Journalists Medical Students Politicians 28,6% 14,3% 14,5% 18,6% 10,4% 13,5% 13,0% 5,1% 0% 21,6% 23,3% 16,5% 9,3% 7,0% 0,0% 2,0% 2,3% 0% 0,0% 0,2% 0,8% 1,1% 1,3% 1,8% Cancer Cerebrovascular disease AIDS Heart disease Liver disease Tuberculosis and pulmonary disease No Answer/ Don'tknow
15 Awareness of the Leading Cause of Death Traffic Accidents Cancer 6,2% 10,8% 6,2% 10,5% 10,6% 16,3% 16,3% 27,0% Politicians Medical Students Journalists Population Cerebrovascular Disease 5,4% 5,9% 5,4% 8,6% AIDS 0,0% 0,2% 0,0% 0,8% Heart Disease 36,1% 53,5% 53,5% 72,0% Liver Cirrhosis Tuberculosis/Pulmonary Disease Don't Know/No Answer 0,0% 0,2% 0,0% 0,3% 0,0% 0,0% 0,8% 0,2% 0,2% 17,7% 17,8% 16,4%
16 Total cholesterol p=0,764 Kruskal-Wallis test
17 Triglycerides p=0,767 Kruskal-Wallis test
18 HDL - cholesterol Population : Parliament p=0,540 Population : Journalists p=0,003 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing
19 LDL - cholesterol Population : Parliament p=0,999 Population : Journalists p=0,027 Journalists : Parliament p=0,045 Mann-Whitney test with correction for multiple testing
20 hs-crp Population : Parliament p=0,999 Population : Journalists p=0,069 Journalists : Parliament p=0,042 Mann-Whitney test with correction for multiple testing
21 Glucose Population : Parliament p=0,999 Population : Journalists p=0,015 Journalists : Parliament p=0,100 Mann-Whitney test with correction for multiple testing
22 HbA1c Population : Parliament p=0,876 Population : Journalists p=0,003 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing
23 Height Population : Parliament p=0,003 Population : Journalists p=0,390 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing
24 Weight Population : Parliament p=0,003 Population : Journalists p=0,999 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing
25 BMI Population : Parliament p=0,003 Population : Journalists p=0,681 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing
26 Waist Population : Parliament p=0,003 Population : Journalists p=0,999 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing
27 Smoking Habits 75% 79% 57% 52% General Population Journalists Medical Students 28% 30% Politicians 22% 18% 15% 18% 3% 3% Smoker Former smoker Non-smoker
28 GP informed about the CV risks High Cholesterol Levels 30,9% 44,1% High Blood Pressure 27,0% 42,6% Smoking 20,6% 22,0% Obesity/Overweight 14,7% 21,1% None 38,2% 52,8% Population Journalists
29 Doctors by Speciality 18,8% 3,0% 12,2% 68,9% Family Doctors Cardiologists Internists Neurologists
30 Following of CVD Prevention Guidelines by Speciality International Atherosclerosis Society guidelines 9,3% 18,4% 16,7% US Guidelines 1,9% 1,4% 1,4% Joint European guidelines from 2007 Joint European guidelines from ,3% 7,1% 3,8% 59,6% 59,1% 71,3% Cardiologists Internists Primary care Institution guidelines 0,9% 2,8% 1,4% Own judgment 7,4% 10,6% 17,5%
31 Guidelines usefulness Do not know guidelines 1,8% 1,2% 1,2% Not useful Fairly useful 0,5% 0,6% 0,3% 20,9% 15,4% 22,9% Cardiologists Internists Primary care Very useful 76,8% 82,7% 75,5%
32 Knowledge of Joint European guidelines recommendation for HDL-chol. in women < 1.2 mmol/l 3,8% 2,5% 6,3% > 1.2 mmol/l 59,2% 58,7% 69,7% < 1.0 mmol/l > 1.0 mmol/l 2,5% 7,0% 6,5% 23,6% 17,4% 21,0% Cardiologists Internists Primary care > 0.9 mmol/l 5,1% 3,0% 3,6% < 0.9 mmol/l 5,7% 0,5% 3,9%
33 Knowledge of Joint European CVD Prevention Guidelines recommendation for blood pressure in high risk patients 120/80 mmhg 38,2% 34,5% 50,5% 130/85 mmhg 39,7% 43,3% 48,5% Cardiologists Internists 150/90 mmhg 8,9% 17,8% 14,1% Primary care 140/90 mmhg 0,6% 2,9% 0,9%
34 Knowledge on optimal blood pressure in high risk patients 37,1% 42,1% 40,0% 45,2% Medical Students Doctors 15,7% 11,2% 6,3% 1,6% <150/90 <140/90 <130/85 <120/80
35 Knowledge of recommended HDLcholesterol in women (mmol/l) 60,2% 34,7% Medical Students Doctors 22,2% 21,1% 14,7% 3,7% 3,6% 3,9% 13,5% 5,9% 11,2% 5,3% <0,9 >0,9 >1,0 <1,0 >1,2 <1,2
36 Knowledge on recommended LDL-cholesterol in patients with diabetes (mmol/l) 56,1% 24,3% 20,5% 30,4% 30,0% 24,8% Medical Students Doctors 7,5% 6,4% <5 <4 <3 <2,5
37 Lowering cholesterol with diet 68,4% 54,5% Medical Student Doctors 26,7% 18,9% 11,9% 9,7% 5,0% 2,7% 1,9% 0,3% 2-3% 10-15% about 50% 50-70% up to 90%
38 Broj ispitanika (%) Do you Believe you Treat Well Your Patients with Hyperlipidemia? Sm atrate li da dobro liječite svoje bolesnike hipelipidem ijom Liječnici OM (N=556) Kardiolozi (N=134) da ne ne znam
39
40
41
42
43 Thank you!
Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
More informationSupplementary Online Content
Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.
More informationESC/EAS GUIDELINES ON MANAGEMENT OF DYSLIPIDEMIAS IN CLINICAL PRACTICE
ESC/EAS GUIDELINES ON MANAGEMENT OF DYSLIPIDEMIAS IN CLINICAL PRACTICE Professor Željko Reiner, MD, PhD,FRCP(Lond), FESC Director, University Hospital Center Zagreb School of Medicine, University of Zagreb,
More informationESC/EAS Guidelines for the Management of Dyslipidaemias
ESC/EAS Guidelines for the Management of Dyslipidaemias Professor Željko Reiner, MD, PhD, FRCP(Lond), FESC, FACC University Hospital Center Zagreb School of Medicine, University of Zagreb, Croatia Declaration
More informationDeprivation Study. The Freiburg Study
The Freiburg Study Deprivation Study Free Radicals Inflammation (hs-crp) Blood Pressure (Systolic, Diastolic) Blood Lipids (Cholesterol, Triglycerides) Energy Utilization (Heart Rate) Sugar Metabolism
More informationTo reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.
E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs
More informationCardiovascular Risk Assessment and Management Making a Difference
Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More information(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
More informationBEST PRACTICE MANAGEMENT: CARDIOVASCULAR RISKS
BEST PRACTICE MANAGEMENT: CARDIOVASCULAR RISKS Neil R Poulter ICCH, Imperial College London BHIVA: October 10th, 2008 Background CVD is the biggest single killer in the world CVD rates are increasing High
More informationESPEN Congress Florence 2008
ESPEN Congress Florence 2008 Severe obesity - Session organised in conjunction with ASPEN The SOS study Setting the Scene A. Thorell (Sweden) The SOS study Setting the Scene Anders Thorell MD, PhD Associate
More informationAndrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University
CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationMetabolic Syndrome: A Preventable & Treatable Cluster of Conditions
Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions April D. McNeill MD Candidate 2016, Southern Illinois University, School of Medicine GE-NMF Primary Care Leadership Program, July 2013
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationNational Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register
National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register The above graph shows a decrease in the number of patients on the
More informationObesity Prevention and Control: Provider Education with Patient Intervention
Obesity Prevention and : Provider Education with Patient Summary Evidence Table and Population Cohen et al. (1991) 1987-1988 : RCT Location: Pittsburgh, PA Physician training session by a behavioral psychologist
More informationDirector, Employee Health & Productivity. Coordinator, Employee Health & Productivity
Director, Employee Health & Productivity Coordinator, Employee Health & Productivity Table 2:. ChartE: Female HDL Cholesterol Risk Levels Optimal Borderline High Risk 80% 60% 40% 20% 0% LDL Cholesterol
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More information2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE
2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE Massimo F Piepoli, MD, PhD, FESC, Piacenza, Italy on behalf of the 6 th Joint Task Force 2 3 Guidelines still based upon the principles of
More informationPlasma Lipids and Global Cardiovascular Risk
Plasma Lipids and Global Cardiovascular Risk Ian Graham Chair JTF4 on the Prevention of CVD and PIC Member ESC/EAS Lipid Guidelines with special thanks to Željko Reiner, Trinity College Dublin- and Zagreb
More informationSupplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationCardiovascular Disease Risk Behaviors of Nursing Students in Nursing School
International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2018, 7(8): 16-33 I J M R
More informationCroatian National Action Network Bone and Joint Decade A 10-YEAR REPORT
HRVATSKI NACIONALNI ODBOR DESETLJEĆE KOSTIJU I ZGLOBOVA 2000-2010. CROATIAN NATIONAL ACTIVE NETWORK THE BONE AND JOINT DECADE 2000-2010. Dubrava University Hospital, Avenija Gojka Šuška 6 10 040 Zagreb
More informationDiabetes Passport. East Coast Area Diabetes Integrated Care
Diabetes Passport East Coast Area Diabetes Integrated Care Personal Details Name: Address: Developed by East Coast Area Diabetes Programme (ECAD), 2014. Thanks to Beaumont Hospital for allowing us to use
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationEuroPRevent Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice
EuroPRevent 2010 Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice G. De Backer Ghent University Ghent, Belgium May 5-8 2010, Prague Czech Republic G. De
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationMetabolic Syndrome in Asians
Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly
More informationJUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study
Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary
More informationDisclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?
Disclosures JUPITER: The final frontier in statin utilization or an idea from outer space? Kathy E. Komperda, PharmD, BCPS Midwestern University Chicago College of Pharmacy kkompe@midwestern.edu 4/25/09
More informationPatient is healthy with no chronic disease or significant risk factors [16%].
AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II
More informationASSeSSing the risk of fatal cardiovascular disease
ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril
More informationSecondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION
Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Dr Kornelia Kotseva National Heart & Lung Insitute Imperial College London, UK on behalf of all investigators participating
More informationPLEASE REMEMBER TO BRING TO EACH APPOINTMENT
PLEASE REMEMBER TO BRING TO EACH APPOINTMENT Conversion table for HbA1c% to mmol/mol Old DCCT aligned HbA1c(%) New IFCC HbA1c (mmol/mol) 4.0 20 5.0 31 6.0 42 6.5 48 7.0 53 7.5 59 8.0 64 9.0 75 10.0 86
More informationProf Rob Doughty Heart Foundation Chair Heart Health University of Auckland. Dr Fraser Hamilton. General Practitioner Heart Foundation Hamilton
Prof Rob Doughty Heart Foundation Chair Heart Health University of Auckland Dr Fraser Hamilton General Practitioner Heart Foundation Hamilton 14:00-14:55 WS #49: Controversies in Cardiovascular Disease
More informationWIN QUARTERLY UTILIZATION REPORT 7/1/2010 TO 12/31/2010. EXPERTISE PARTNERSHIP V A L U E April 20, 2011
WIN QUARTERLY UTILIZATION REPORT 7/1/2010 TO 12/31/2010 EXPERTISE PARTNERSHIP V A L U E April 20, 2011 T R E N D S A N A L Y S I S S T A T I S T I C S P L A N N I N G T O O L S Participation Mass Screening
More informationAdult Pre Participation Screening and Exercise Prescription Practicum
Adult Pre Participation Screening and Exercise Prescription Practicum Objectives of this exercise: To administer pre participation screening and risk stratification for clients To write an appropriate
More informationMississippi Stroke Systems of Care
Stroke Initiatives Mississippi State Department of Health Cassandra Dove, Chronic Disease Bureau 19 th Annual Stroke Belt Consortium March 1, 2014 Mississippi Stroke Systems of Care Heart Disease and Stroke
More informationControversies in Preventative Cardiology
Controversies in Preventative Cardiology Francisco Lopez-Jimenez, M.D., M.Sc, FACC, FAHA Professor of Medicine, Mayo Medical School Chair, Division of Preventive Cardiology Co-Director, Artificial Intelligence
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More informationApelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure
Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure CI Liakos, 1 EA Sanidas, 1 DN Perrea, 1 V Gennimata, 1 V Chantziara, 1 CA Grassos, 2 N-A Viniou, 1 JD Barbetseas,
More informationSupplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups
Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate
More informationDIABETES. A growing problem
DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought
More informationCorporate Health Screening
Corporate Health Screening What should I look out for? Presented by: Dr Wee Wei Keong Director Health for Life Programme WHAT IS HEALTH SCREENING? Tests/procedures carried out to detect a condition/disease
More informationCARE PATHWAYS. Allyson Ashley
CARE PATHWAYS Allyson Ashley WHAT IS A CARE PATHWAY? An explicit statement of the goals and key elements of care based on evidence, best practice, and patient s expectations and their characteristics The
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationPrevention in Europe
Prevention in Europe Geneviève Derumeaux Créteil University, France Ian M Graham Trinity College, Dublin ESC: 2016 Lipid guidelines 2016 Joint Prevention Guidelines Cardiovascular disease in Europe Nick
More informationThe JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009
The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain
More informationTHE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT
THE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT Siti Hajar MH 1, Harmy MY 1, Norhayati MN 1, Aida HGR 2, Hamid JJM 3 Department
More information290 Biomed Environ Sci, 2016; 29(4):
290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur
More informationCase Study: Chris Arden. Peripheral Arterial Disease
Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she
More informationJohn s Labs & Tests (for December 1, 2012)
4 John s Labs & Tests (for December 1, ) Page 1 of 2 You had the following labs/studies performed: Ankle Brachial Pressure Index is the ratio of blood pressure in your legs divided by the blood pressure
More informationHealth First. New Health Bucks Program MANATEE YOURCHOICE HEALTH PLAN
Health First New Health Bucks Program MANATEE YOURCHOICE HEALTH PLAN www.manateeyourchoice.com/healthfirst A special thanks to Aetna for covering the printing costs of this booklet. CONTENTS OUR PURPOSE
More informationPage 1. Disclosures. Background. No disclosures
Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen
More informationMarshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,
Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationORIGINAL ARTICLE. Abstract. Introduction
ORIGINAL ARTICLE Health Education Hokenshido Program Reduced Metabolic Syndrome in the Amagasaki Visceral Fat Study. Three-Year Follow-up Study of 3,174 Japanese Employees Miwa Ryo 1, Tadashi Nakamura
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationCorrespondence should be addressed to Peng-Fei Shan;
International Endocrinology Volume 2016, Article ID 8483405, 7 pages http://dx.doi.org/10.1155/2016/8483405 Research Article Gender Differences in Risks of Coronary Heart Disease and Stroke in Patients
More informationClinical Care Performance. Financial Year 2012 to 2018
Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c
More informationRegional of national clinical data. Do they help me to improve my practice? Rob Dijkstra, GP Dutch College of General Practitioners
Regional of national clinical data Do they help me to improve my practice? Rob Dijkstra, GP Dutch College of General Practitioners General practice outline How does it work in my practice? examples of
More informationwell-targeted primary prevention of cardiovascular disease: an underused high-value intervention?
well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? Rod Jackson University of Auckland, New Zealand October 2015 Lancet 1999; 353: 1547-57 Findings: Contribution
More informationDiscussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting
Session #5 Cardiometabolic Risk Management in the Primary Care Setting Sonja Reichert, MD MSc FCFP FACPM Betty Harvey, RNEC BScN MScN Amanda Mikalachki, RN BScN CDE S Discussion points Whom should we be
More informationNutrition Care Process. Catherine Villafranca & Anthony Richitt
Nutrition Care Process Catherine Villafranca & Anthony Richitt Nutrition Care Process -According to eatrightpro.org, the Nutrition Care Process is a systematic approach to providing high-quality nutrition
More informationABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN?
ABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN? W.H. OLDEWAGE-THERON & A.A. EGAL Centre of Sustainable Livelihoods, Vaal University of Technology,
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationIdentification of subjects at high risk for cardiovascular disease
Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet
More informationPut your Heart before your Head
Put your Heart before your Head Alok K Gupta, MD, FAAFP, FASH Associate Professor, Outpatient Clinic since 1963, the US Congress has required the President to proclaim February "American Heart Month."
More information30% of patients with T2D have high levels of urine albumin at diagnosis: 75% MAU 25% overt diabetic nephropathy
Identifying Patients with Type 2 Diabetes at High Risk of Microalbuminuria: the DEMAND (Developing Education on Microalbuminuria for Awareness of renal and cardiovascular risk in Diabetes) Study. Rossi
More informationDr Anne King dc life dclife.co.uk
The Vampire Strikes Back Dr Anne King dc life dclife.co.uk Overview Clinical -v- Underwriting Blood physiology The blood sample Screening for the 3 main killers The top 3 useful blood tests The future
More informationWhy are NICE guidelines and standards important and relevant to us?
Why are NICE guidelines and standards important and relevant to us? Dr Liz England GP, Laurie Pike health centre RCGP Mental Health Clinical and Commissioning Lead SWB CCG Mental Health Lead NIHR Clinical
More informationDiabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center
Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??
More information6/10/2016. Hui-Chun Hsu
Hui-Chun Hsu PhD, RN, CDE Chief, Department of Diabetes Management Lee s Endocrinology Clinic Pingtung, Taiwan Disclosure to Participants Conflict of Interest (COI) and Financial Relationship Disclosures:
More informationEffect of Combined Interventions of Diet and Physical Activity on the Perceived and Actual Risk of Coronary
World Journal of Medical Sciences 9 (4): 282-288, 2013 ISSN 1817-3055 IDOSI Publications, 2013 DOI: 10.5829/idosi.wjms.2013.9.4.12383 Effect of Combined Interventions of Diet and Physical Activity on the
More informationHeart Age and Cardiovascular Risk
Heart Age and Cardiovascular Risk Mark Cobain Unilever R+D Colworth Science Park Sharnbrook Bedfordshire Europrevent, Geneva April 16 2011 Conflict of Interest Statement Employment by Unilever PLC A producer
More informationEvaluation of ischemia-modified albumin levels and parametersof arterial stiffness in patients with hypothyroidism
Annals of Medical Research DOI: 10.5455/annalsmedres.2018.08.154 2019;26(1):32-6 Original Article Evaluation of ischemia-modified albumin levels and parametersof arterial stiffness in patients with Andac
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationTrends In CVD, Related Risk Factors, Prevention and Control In China
Trends In CVD, Related Risk Factors, Prevention and Control In China Youfa Wang, MD, MS, PhD Associate Professor Center for Human Nutrition Department of International Health Department of Epidemiology
More informationSupplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
More informationHEART RATE IN PATIENTS WITH CORONARY ARTERY DISEASE IN LATVIA
Inga Balode HEART RATE IN PATIENTS WITH CORONARY ARTERY DISEASE IN LATVIA Summary of the Doctoral Thesis for obtaining the degree of a Doctor of Medicine Speciality Internal Medicine Riga, 2014 Doctoral
More informationAppendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.
Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular
More informationPatient Education. intermountainhealthcare.org/diabetes. BG Tracker. for people with diabetes MONITORING BLOOD GLUCOSE
Patient Education intermountainhealthcare.org/diabetes Tracker for people with diabetes MONITORING BLOOD GLUCOSE Title Case My name/phone: Contact numbers: Healthcare provider: Diabetes educator: Pharmacy:
More informationAbstract. Research Methods. Muneer Mohammad Bustanji (1) Sawsan Majali (2)
Effect of Combined Interventions of Diet and Physical Activity on the Perceived and Actual Risk of Coronary Heart Disease among Women in North of Jordan Muneer Mohammad Bustanji (1) Sawsan Majali (2) (1)
More informationAmerican Journal of Oral Medicine and Radiology
American Journal of Oral Medicine and Radiology e - ISSN - XXXX-XXXX ISSN - 2394-7721 Journal homepage: www.mcmed.us/journal/ajomr PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE AMONG TYPE 2 DIABETIC POPULATION
More informationThe Clinical Debates
The Clinical Debates Speakers: Round 2: Statins for Primary Prevention of Cardiovascular Disease Matthew Cantrell, PharmD, BCPS, is a 2000 graduate of Mt. Mercy College and 2005 graduate from the University
More informationFaculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers
Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers Nada Abu-Kishk Health Nutrition Officer at UNRWA-HQ What is UNRWA (United Nations
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationRISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES
RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet
More informationANNUAL HEALTH CHECKUP BASIC HEALTH PACKAGE
ANNUAL HEALTH CHECKUP Taking care of your health is our responsibility and to make sure that you remain at a distance from the serious maladies, we also step forward in providing health checkups. This
More informationMethods. Background and Objectives STRADIVARIUS
STRADIVARIUS Effect of on Progression of Atherosclerosis in Patients with Abdominal Obesity and Coronary Artery Disease Steven E. Nissen MD Stephen J. Nicholls MBBS PhD, Kathy Wolski MPH, Josep Rodés-Cabau
More informationAbstract. (Left Mouse-click to begin and move to next slide.)
Abstract (Left Mouse-click to begin and move to next slide.) A Comparison of Pulse Pressure, Arterial Stiffness, and Endothelial Function for the Diagnosis and Prognostic Risk of Coronary Heart Disease
More informationHealth Indicators and Status in the European Union
Elmadfa I,Weichselbaum E (eds): European Nutrition and Health Report 4. Forum Nutr. Basel, Karger, 5, vol 58, pp 47 61 Health Indicators and Status in the European Prevalence of Overweight and Obesity
More informationAdiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance.
ORIGINAL ARTICLE Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance. Bonneau GA y Pedrozo WR 1 Ministry of Public Health, Province of Misiones, 2 School of Exact, Chemical
More information